Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Myriad Genetics Inc. (MYGN)

NASDAQ

$4.34

$+0.05

(+1.17%)

Myriad Genetics Inc. (MYGN) Live Price Chart

Page last updated: 2026-03-30 15:58:00

Key Market Data

Market Cap	$406.01M
Open	$4.28
High	$50.44
Low	$3.76
Previous Close	$4.28
Price Change	$+0.05
Percentage Change	+1.17%
Volume	355K

Myriad Genetics Inc. (MYGN) Stock Price Today

Myriad Genetics Inc. (MYGN) is currently trading at $4.34 as of 2026-03-30 15:58:00, reflecting a +1.17% move ($+0.05) from the previous close.

In the short term, the stock has returned -13.33% over the past four weeks. Over the last 12 months, Myriad Genetics Inc. has recorded a -51.05% price change, indicating a weak performance relative to the broader market.

Myriad Genetics Inc. (MYGN) 7-Day Stock Price Changes

Over the past seven days, Myriad Genetics Inc. has traded within a short-term range shaped by market sentiment in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. During this period, the stock moved from its previous closing price of $4.64 to the latest recorded price of $4.34, reflecting an intraday change of +1.17%. Daily movements highlight shifts in trading volume (354,873), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, MYGN has delivered a -13.33% return over the past month and a -51.05% change in the last 12 months, indicating a weak trend relative to its broader sector peers.

How to Buy Myriad Genetics Inc. (MYGN)

You can buy and trade MYGN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for MYGN and Execute Your Trade

Open the trading page, enter MYGN in the search bar, select the amount of MYGN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Myriad Genetics Inc. (MYGN)?

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Myriad Genetics Inc. Information

Industry	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Employees	2,700
Sector	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Company Website	https://www.myriad.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Myriad Genetics Inc.?

The latest trading price for Myriad Genetics Inc. (Common Stock) is $ 4.34, compared with a previous closing price of $ 4.28. That means the stock has moved +1.17% so far today. Intraday price updates and recent trading activity for MYGN can be tracked on the live chart and quote section on this page.

2.Is Myriad Genetics Inc. stock going up or down?

Looking at recent performances, MYGN has returned -13.33% over the past month, -42.57% over the last six months and -51.05% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe weak price momentum for Myriad Genetics Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does MYGN currently sit relative to its 52-week high and low?

In the most recent 52-week period, Myriad Genetics Inc. has traded between a low of $ 3.76 and a high of $ 9.02. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether MYGN is currently nearer the top or the bottom of its one-year trading band.

4.How is Myriad Genetics Inc. classified by sector and industry?

Myriad Genetics Inc. is classified in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. In practice, this means Myriad Genetics Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing MYGN’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector could influence Myriad Genetics Inc.’s performance.

5.Where is Myriad Genetics Inc. listed and how large is it by market value?

Myriad Genetics Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 406.01M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Myriad Genetics Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does MYGN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -3.91 summarises how much profit Myriad Genetics Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Myriad Genetics Inc.'s financial performance over time?

To follow Myriad Genetics Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how MYGN is performing and how the market is responding.

8.When is Myriad Genetics Inc. expected to report earnings?

Myriad Genetics Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for MYGN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Myriad Genetics Inc.'s earnings reports?

Myriad Genetics Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether MYGN is meeting, beating or missing expectations.

10.How can I stay informed about Myriad Genetics Inc.'s results and guidance?

You can stay up to date on Myriad Genetics Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for MYGN on this page helps you see how new information is being reflected in the stock.

11.Does Myriad Genetics Inc. pay a regular cash dividend to its shareholders?

Myriad Genetics Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor MYGN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for MYGN?

Based on the latest earnings data, MYGN has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Myriad Genetics Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Myriad Genetics Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Myriad Genetics Inc.?

Myriad Genetics Inc. is a publicly traded company in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry within the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is MYGN valued in terms of P/E ratio and EPS?

Myriad Genetics Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -3.91. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Myriad Genetics Inc.'s earnings. Comparing MYGN's P/E and EPS to those of other IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Myriad Genetics Inc.

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Berkshire Hathaway Inc.

BRK.A

Alphabet Inc.

GOOG

Most Actively Traded

Discover today's most actively traded US stocks

Alkermes Inc. plc

ALKS

Grocery Outlet Holding Corp.

Heron Therapeutics, Inc.

HRTX

Inhibikase Therapeutics, Inc.

IKT

John B. Sanfilippo & SON

JBSS

Top Gainers

Browse today's leading gainers in the US stock market

Astrotech Corporation (DE)

ASTC

American Vanguard Corporation

AVD

Bullfrog AI Holdings, Inc.

BFRG

PMGC Holdings Inc.

ELAB

Visionary Holdings Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

MYGN-to-USD Calculator

Amount

MYGN

USD

1 MYGN = 4.342 USD